LivaNova PLC (LIVN)

NASDAQ: LIVN · IEX Real-Time Price · USD
67.53
1.51 (2.29%)
May 27, 2022 4:00 PM EDT - Market closed
Market Cap3.61B
Revenue (ttm)1.03B
Net Income (ttm)-103.13M
Shares Out53.44M
EPS (ttm)-1.97
PE Ration/a
Forward PE24.45
Dividendn/a
Ex-Dividend Daten/a
Volume211,422
Open66.61
Previous Close66.02
Day's Range65.97 - 67.66
52-Week Range58.18 - 93.89
Beta0.90
AnalystsBuy
Price Target102.34 (+51.5%)
Earnings DateMay 4, 2022

About LIVN

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device tha...

IndustryHealth Care Equipment & Supplies
IPO DateFeb 10, 1993
CEODamien McDonald
Employees3,000
Stock ExchangeNASDAQ
Ticker SymbolLIVN
Full Company Profile

Financial Performance

In 2021, LivaNova's revenue was $1.04 billion, an increase of 10.82% compared to the previous year's $934.24 million. Losses were -$135.82 million, -61.06% less than in 2020.

Financial Statements

Analyst Forecast

According to 12 analysts, the average rating for LIVN stock is "Buy." The 12-month stock price forecast is 102.34, which is an increase of 51.55% from the latest price.

Price Target
$102.34
(51.55% upside)
Analyst Consensus: Buy
Stock Forecasts

News

LivaNova to Present at the Goldman Sachs Global Healthcare Conference

LONDON--(BUSINESS WIRE)--LivaNova PLC announced CEO Damien McDonald will present in a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 15.

2 days ago - Business Wire

LivaNova (LIVN) Lags Q1 Earnings Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of -7.69% and 3.09%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

3 weeks ago - Zacks Investment Research

LivaNova Reports First-Quarter 2022 Results

LONDON--(BUSINESS WIRE)-- #advancedcirculatorysupport--LivaNova PLC, a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2022.

3 weeks ago - Business Wire

LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass Procedures

LONDON--(BUSINESS WIRE)--LivaNova PLC today announced receipt of regulatory approvals and the start of a targeted commercial launch for the Essenz Patient Monitor.

1 month ago - Business Wire

LivaNova to Announce First-Quarter 2022 Results

LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova PLC will host a conference call to discuss its first-quarter 2022 results on Wednesday, May 4, 2022 at 1 p.m. London time (8 a.m. EDT).

2 months ago - Business Wire

LivaNova Announces 250th Unipolar Depression Patient Implanted in RECOVER Clinical Study

LONDON--(BUSINESS WIRE)-- #depression--LivaNova PLC today announced the 250th unipolar depression patient has been implanted in the RECOVER clinical study.

2 months ago - Business Wire

7 Top David Einhorn Stock Picks to Add to Your March Buy List

David Einhorn stocks did better than the S&P 500 in Q4 2021, gaining 18.6%, 760 basis points higher. Buy these seven holdings.

2 months ago - InvestorPlace

LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea

LONDON--(BUSINESS WIRE)-- #livn--LivaNova PLC announced the first patient implanted in clinical study, “Treating Obstructive Sleep Apnea using Targeted Hypoglossal Neurostimulation.”

3 months ago - Business Wire

LivaNova (LIVN) Surpasses Q4 Earnings and Revenue Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of 14% and 2.54%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

LivaNova Reports Fourth-Quarter and Full-Year 2021 Results

LONDON--(BUSINESS WIRE)-- #advancedcirculatorysupport--LivaNova PLC today reported results for the quarter and full year ended December 31, 2021.

3 months ago - Business Wire

Can LivaNova (LIVN) Keep the Earnings Surprise Streak Alive?

LivaNova (LIVN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

3 months ago - Zacks Investment Research

LivaNova to Announce Fourth-Quarter and Full-Year 2021 Results

LONDON--(BUSINESS WIRE)-- #advancedcirculatorysupport--LivaNova PLC will host a conference call to discuss its fourth-quarter and full-year 2021 results on Wed., Feb. 23, 2022 at 1 p.m. London (8 a.m. ET)

4 months ago - Business Wire

LivaNova to Present Scientific Data on VNS Therapy for Drug-Resistant Epilepsy at American Epilepsy Society 2021 Annu...

LONDON--(BUSINESS WIRE)-- #epilepsy--LivaNova PLC today announced its participation in the American Epilepsy Society Annual Meeting taking place December 3 – 7 in Chicago, Illinois.

5 months ago - Business Wire

LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimu...

LONDON--(BUSINESS WIRE)--LivaNova PLC today announced its participation in the 4th International Brain Stimulation Conference, taking place December 6 - 9 in Charleston, S.C.

5 months ago - Business Wire

LivaNova to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

LONDON--(BUSINESS WIRE)-- #cardiovascular--LivaNova PLC announced Damien McDonald, CEO, will participate in discussions at the Piper Sandler 33rd Annual Virtual Healthcare Conference on Dec. 1.

6 months ago - Business Wire

LivaNova Comments on Decision by Court of Appeal of Milan

LONDON--(BUSINESS WIRE)--LivaNova commented on the decision delivered today by the Court of Appeal of Milan for LivaNova to pay damages as a result of a civil action.

6 months ago - Business Wire

LivaNova to Present at the 2021 Stifel and Jefferies Healthcare Conferences

LONDON--(BUSINESS WIRE)-- #cardiovascular--LivaNova announced CEO Damien McDonald will present at Stifel 2021 Virtual Healthcare Conference and at Jefferies 2021 London Healthcare Conference.

6 months ago - Business Wire

LivaNova Announces 2021 Virtual Investor Day

LONDON--(BUSINESS WIRE)-- #cardiovascular--LivaNova today announced it will host a virtual Investor Day on December 7 from 8 a.m.-12 p.m. Central Time (9 a.m.-1 p.m. Eastern Time).

6 months ago - Business Wire

LivaNova Shares Move Higher On Street-Beating Q3 Earnings

LivaNova PLC (NASDAQ: LIVN) posted Q3 sales of $253.2 million, +5.5% Y/Y on a reported basis and 5% on a constant-currency basis, beating the consensus of $245.27 million. Excluding Heart Valves busines...

6 months ago - Benzinga

LivaNova (LIVN) Q3 Earnings and Revenues Surpass Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of 51.11% and 3.21%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

LivaNova Reports Third Quarter 2021 Results

LONDON--(BUSINESS WIRE)-- #cardiovascular--LivaNova PLC, a market-leading medical technology and innovation company, today reported results for the quarter ended September 30, 2021.

6 months ago - Business Wire

LivaNova (LIVN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

7 months ago - Zacks Investment Research

LivaNova (LIVN) Sees Hammer Chart Pattern: Time to Buy?

LivaNova (LIVN) has been struggling lately, but the selling pressure may be coming to an end soon.

7 months ago - Zacks Investment Research

LivaNova to Host Conference Call for Third Quarter 2021 Results

LONDON--(BUSINESS WIRE)-- #cardiovascular--LivaNova PLC will host a conference call to discuss its third quarter 2021 results on Wednesday, Nov. 3, 2021 at 12 p.m. London/8 a.m. Eastern time.

7 months ago - Business Wire

10 Expensive Stocks to Steer Clear Of

Expensive stocks with mediocre growth prospects can drop the most when the whole market starts to slide. These 10 stocks could be at high risk.

8 months ago - Kiplinger